Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Maria Cebollero"'
Autor:
Esther Conde, MD, PhD, Susana Hernandez, PhD, Jose Luis Rodriguez Carrillo, MD, Rebeca Martinez, APT, Marta Alonso, APT, Daniel Curto, MD, Beatriz Jimenez, MD, Alejandra Caminoa, MD, PhD, Amparo Benito, MD, Pilar Garrido, MD, PhD, Sergi Clave, PhD, Edurne Arriola, MD, PhD, Isabel Esteban-Rodriguez, MD, PhD, Javier De Castro, MD, PhD, Irene Sansano, MD, Enriqueta Felip, MD, PhD, Federico Rojo, MD, PhD, Manuel Dómine, MD, PhD, Ihab Abdulkader, MD, PhD, Jorge Garcia-Gonzalez, MD, Cristina Teixido, PhD, Noemi Reguart, MD, PhD, Desamparados Compañ, MD, PhD, Amelia Insa, MD, Nuria Mancheño, MD, PhD, Sarai Palanca, MD, PhD, Oscar Juan-Vidal, MD, PhD, Nuria Baixeras, MD, Ernest Nadal, MD, PhD, Maria Cebollero, MD, Antonio Calles, MD, Paloma Martin, MD, PhD, Clara Salas, MD, PhD, Mariano Provencio, MD, PhD, Ignacio Aranda, MD, PhD, Bartomeu Massuti, MD, Laura Lopez-Vilaro, MD, Margarita Majem, MD, PhD, Luis Paz-Ares, MD, PhD, Fernando Lopez-Rios, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 4, Pp 100653- (2024)
Introduction: RET inhibitors with impressive overall response rates are now available for patients with NSCLC, yet the identification of RET fusions remains a difficult challenge. Most guidelines encourage the upfront use of next-generation sequencin
Externí odkaz:
https://doaj.org/article/a3e58ca9d39948fda3972ff1d75a8f34
Autor:
Miguel Martin, Rocio Ramos-Medina, Rebeca Bernat, Jose Angel García-Saenz, Maria del Monte-Millan, Enrique Alvarez, Maria Cebollero, Fernando Moreno, Eva Gonzalez-Haba, Oscar Bueno, Paula Romero, Tatiana Massarrah, Isabel Echavarria, Yolanda Jerez, Blanca Herrero, Ricardo Gonzalez del Val, Nerea Lobato, Patricia Rincon, Maria Isabel Palomero, Ivan Marquez-Rodas, Santiago Lizarraga, Fernando Asensio, Sara Lopez-Tarruella
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Triple-negative breast cancer (TNBC) is highly responsive to neoadjuvant polychemotherapy regimens including anthracyclines, taxanes, and, more recently, carboplatin. However, there is inadequate information on the individual contribution of
Externí odkaz:
https://doaj.org/article/6320cb09619d46bdb0b5fd843bc4c5e3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ivan Marquez-Rodas, Tatiana Massarrah, María del Monte-Millán, Patricia Rincon, Isabel Echavarria, Ana Isabel Ballesteros, S. Lizarraga, Coralia Bueno-Muiño, Lucía Villarejo, Uriel Bohn, José Ángel García Sáenz, Rocío Ramos-Medina, Blanca Herrero, Yolanda Jerez, Nerea Lobato, Sara López-Tarruella, Maria Cebollero, Miguel Martín, Ricardo González del Val, Fernando Salvador Moreno, Enrique Alvarez, María Isabel Palomero, Charles M. Perou, Inmaculada Ocaña
Publikováno v:
Cancer Research. 81:PS4-12
Background: TNBC is a particularly aggressive subtype with high recurrence rates and poor long-term survival. Anthracycline-free regimens based on docetaxel plus carboplatin (TCb) achieve around 50-55% pathologic complete responses (pCR) which correl
Autor:
Maria Cebollero Presmanes, Patricia Nuñez Ramos, Diego Muñoz Moreno, Laura González Fernández, Marcel Sambo Salas
Publikováno v:
Clinical Nuclear Medicine. 47:e34-e36
Ectopic differentiated thyroid carcinoma represents less than 1% of all thyroid carcinoma cases, which usually arises along the cervical midline, and (delving into literature) there are scarce reports of such entity in nuclear medicine imaging studie
Autor:
María del Monte-Millán, Patricia Rincon, Ivan Marquez-Rodas, Rebeca Bernat, José A. García-Sáenz, Isabel Echavarria, Paula Romero, Yolanda Jerez, Sara López-Tarruella, Rocío Ramos-Medina, Ricardo González del Val, Fernando Asensio, Eva González-Haba, Nerea Lobato, María Isabel Palomero, Miguel Martín, Fernando Salvador Moreno, Enrique Alvarez, Blanca Herrero, Tatiana Massarrah, Oscar Bueno, S. Lizarraga, Maria Cebollero
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Triple-negative breast cancer (TNBC) is highly responsive to neoadjuvant polychemotherapy regimens including anthracyclines, taxanes, and, more recently, carboplatin. However, there is inadequate information on the individual contribution of each of
Autor:
Miguel Martin, Rocio Ramos-Medina, Rebeca Bernat, Jose Angel Garcia Saenz, Maria Del Monte-Millan, Enrique Alvarez, Maria Cebollero, Fernando Moreno, Eva Gonzalez Haba, Oscar Bueno, Paula Romero, Tatiana Massarrah, Isabel Echavarria, Yolanda Jerez, Blanca Herrero, Ricardo Gonzalez Del Val, Nerea Lobato, Patricia Rincon, Maria Isabel Palomero, Ivan Marquez-Rodas, Santiago Lizarraga, Fernando Asensio, Sara Lopez-Tarruella
Background: Triple-negative breast cancer (TNBC) is highly responsive to neoadjuvant polychemotherapy regimens including anthracyclines, taxanes, and, more recently, carboplatin. However, there is inadequate information on the individual contribution
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11249e33d57a11a01beba9dd4cddb109
https://doi.org/10.21203/rs.3.rs-57678/v1
https://doi.org/10.21203/rs.3.rs-57678/v1
Autor:
Isabel Echavarria, Ana Isabel Ballesteros, Tatiana Massarrah, Agustí Barnadas, Katherine A. Hoadley, Rocío Ramos-Medina, Miguel Martin, Uriel Bohn, Maria Cebollero, Henry L. Gomez, Hugo Fuentes, Yolanda Jerez, Antoni Picornell, Fernando Salvador Moreno, Ivan Marquez-Rodas, Sara López-Tarruella, Enrique Alvarez, Charles M. Perou, Javier Gayarre, María del Monte-Millán, José A. García-Sáenz, Inmaculada Ocaña
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
CLINICAL CANCER RESEARCH
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Consejería de Sanidad de la Comunidad de Madrid
CLINICAL CANCER RESEARCH
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Purpose: Triple-negative breast cancer (TNBC) requires the iden- tification of reliable predictors of response to neoadjuvant chemotherapy (NACT). For this purpose, we aimed to evaluate the performance of the TNBCtype-4 classifier in a cohort of pati
Autor:
Isabel Echavarria, Ana Isabel Ballesteros, J. A. Garcia Saenz, Katherine A. Hoadley, Rocío Ramos-Medina, Yolanda Jerez, Antoni Picornell, Javier Gayarre, M. del Monte-Millán, Enrique Alvarez, M. Ruiz Borrego, M. Martin, Joel S. Parker, Sara López-Tarruella, Inmaculada Ocaña, Tatiana Massarrah, Fernando Salvador Moreno, Charles M. Perou, Maria Cebollero, H. Gomez Moreno
Publikováno v:
BMC Genomics, Vol 20, Iss 1, Pp 1-11 (2019)
Digital.CSIC. Repositorio Institucional del CSIC
instname
BMC Genomics
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Digital.CSIC. Repositorio Institucional del CSIC
instname
BMC Genomics
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
[Background]: Full RNA-Seq is a fundamental research tool for whole transcriptome analysis. However, it is too costly and time consuming to be used in routine clinical practice. We evaluated the transcript quantification agreement between RNA-Seq and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15af69da654ee268964110134d380685
https://hdl.handle.net/10668/14068
https://hdl.handle.net/10668/14068
Autor:
S. Lizarraga, Ricardo González del Val, Miriam Lobo, Ivan Marquez-Rodas, Carmen Flores-Sánchez, Jesus Solera, Miguel Martin, Yolanda Jerez, Maria Cebollero, María Isabel Palomero, Soledad Luque, Oscar Bueno, Isabel Echavarria, Gabriela Torres, Sara López-Tarruella
Publikováno v:
Journal of genetic counseling. 27(4)
The identification of patients at risk for breast cancer by genetic testing has proven to reduce breast cancer mortality. In 2010, due to a lack of systematization in hereditary cancer assistance in our center, we implemented a multidisciplinary Here